Conquering the Cancer Care Continuum – Series Three: Third Issue

As an oncology pharmacist in an ambulatory cancer clinic, in the course of a typical week, it is not unusual for me to counsel 25 to 30 new patients on chemotherapy regimens that they are about to receive (paying particular attention to adverse events [AEs]), and to be directly involved in the monitoring and management of countless other patients who present with side effects associated with their treatments.

Among the various types of treatment that a patient with cancer may undergo, chemotherapy is associated with the greatest concerns with respect to side effects.